日本av大全免费,久久综合欧美成人

當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

ENMD-2076
ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM, 25-fold selective for Aurora
2016-01-05 13:35 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂
詢價(jià)

Inolitazone
Inolitazone(RS5444; CS-7017) is a novel high-affinity PPAR agonist, which activates PPAR with an EC50 about 1/50 that of
2016-01-05 13:33 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

3329.00/5mg
05mg起訂
詢價(jià)

Retaspimycin
Retaspimycin(IPI 504) is a small-molecule inhibitor of heat shock protein 90 (HSP90) with antiproliferative and antineop
2016-01-05 13:31 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

2558.00/10mg
010mg起訂
詢價(jià)

chroman 1
chroman 1 is a highly potent and selective ROCK II inhibitor.IC50 value:Target: ROCK II公司介紹：MedChemExpress(MCE)專注
2016-01-05 13:29 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

5254.00/10mg
010mg起訂
詢價(jià)

DBeQ
DBeQ(JRF-12) is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 M.IC50 value: 1.5 uM
2016-01-05 13:27 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

558.00/5mg
05mg起訂
詢價(jià)

RI-1
RI-1 is a RAD51 inhibitor with IC50 ranging from 5 to 30 M.IC50 Value: 5-30 MTarget: RAD51in vitro: RI-1 sensitizes cell
2016-01-05 13:26 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1580.00/5mg
05mg起訂
詢價(jià)

CVT-313
CVT-313(NG-26) is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 (IC50 = 0.5 uM for Cdk2/A and C
2016-01-05 13:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

818.00/5mg
05mg起訂
詢價(jià)

CCT 137690
CCT 137690 is a potent inhibitor of Aurora kinases (IC50 values are 0.015, 0.019 and 0.025 M at Aurora A, Aurora C and A
2016-01-05 13:21 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

790.00/5mg
05mg起訂
詢價(jià)

AT7519 (Hydrochloride)
AT7519 hydrochloride is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM; is less potent to CDK3 and
2016-01-04 17:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1488.00/10mg
010mg起訂
詢價(jià)

Ganetespib
Ganetespib(STA-9090) is a unique triazolone-containing Hsp90 inhibitor with an IC50 of 4 nM in OSA 8 cells.公司介紹：專
2016-01-04 17:27 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

2727.00/10mg
010mg起訂
詢價(jià)

MK-5108
MK-5108 (VX-689) is a highly selective Aurora A inhibitor with IC50 of 0.064 nM; 220- and 190-fold more selective for Au
2016-01-04 17:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1989.00/5mg
05mg起訂
詢價(jià)

PF-03814735
PF-03814735 is a novel, potent, orally bioavailable, reversible small-molecule Aurora kinase inhibitor with IC50 of 0.8,
2016-01-04 17:18 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂
詢價(jià)

Mitoxantrone
Mitoxantrone, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.Target: Topoisomeras
2016-01-04 17:16 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

515.00/50mg
050mg起訂
詢價(jià)

Poloxin
Poloxin is a non-ATP competitive Polo-like Kinase 1 (PLK1) inhibitor that targets the polo-box domain.公司介紹：專注于各
2016-01-04 17:15 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

577.00/10mg
010mg起訂
詢價(jià)

BS-181 (hydrochloride)
BS-181 is a highly selective CDK7 inhibitor with IC50 of 21 nM.公司介紹：專注于各種抑制劑、激動(dòng)劑、及化合物庫，總部位于
2016-01-04 17:13 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

360.00/100mg
0100mg起訂
詢價(jià)

Cisplatin
Cisplatin(CDDP) is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts.公司
2016-01-04 17:10 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

360.00/100mg
0100mg起訂
詢價(jià)

TAK-960 (hydrochloride)
TAK-960 hydrochloride is a novel, investigational, orally bioavailable, potent, and selective PLK1 inhibitor(IC50=1.5 nM
2016-01-04 17:08 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1300.00/5mg
05mg起訂
詢價(jià)

SNS-314
SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respe
2016-01-04 17:06 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

884.00/5mg
05mg起訂
詢價(jià)

CYC-116
CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM.IC50 Value: 8.0 nM(Aurora A); 9.2 nM(Aurora B)Target
2016-01-04 17:04 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

921.00/10mg
010mg起訂
詢價(jià)

AT9283
AT9283 is a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, A
2016-01-04 17:02 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]